Effect of radiation on the human reproductive system. by Ogilvy-Stuart, A L & Shalet, S M
Environmental Health Perspectives Supplements
101 (Suppl. 2): 109-116 (1993)
Effect of Radiation on the Human
Reproductive System
by Amanda L. Ogilvy-Stuart' and Stephen M. Shalet1
Irradiation may have a profound effect on reproductive function. The schedule ofthe delivered irradiation
(total dose,numberoffractions, andduration) isanimportantdeterminantoftheradiobiological effectonthe
tissues involved andvaries amongdifferent tissues and organs. Irradiation to the central nervous system may
affectthetimingofthe onsetofpuberty, result in hyperprolactinemia, orcause gonadotropin deficiency ifthe
hypothalamic-pituitary axis is involved in the radiation field. Direct irradiation to the testis will, in lower
doses, affectthe germinal epithelium: doses ofirradiation greaterthan 0.35 Gycause aspermia, which may be
reversible. The time taken for recovery increases with larger doses; however, with doses in excess of 2 Gy
aspermia maybe permanent. At higherradiation doses (> 15 Gy), Leydigcell function will also be affected. In
addition toradiation dose,thevulnerability ofthetestis isdependentontheageatirradiationandthepubertal
status ofthe male. In the female, the response ofthe ovaryto the effects ofirradiationvaries with age as well
as dose, and separation ofovarian dysfunction into hormonal and fertility effects is not clearcut. An ovarian
doseof4Gymaycausea30% incidenceofsterility inyoungwomen,but100%sterility inwomenover40yearsof
age. Pelvic irradiation may also have aprofound effect on the uterus, with arrested growth in the prepubertal
girl, and failure ofuterine expansion during pregnancy with subsequent miscarriages and premature labor.
Introduction
Information about the impact of environmental radia-
tion onreproductive functionmightbederivedfromstudy-
ing the effects of radiation accidents in the community.
There are, however, few reports of reproductive function
following radiation accidents because the radiation doses
are not accurately known, and the effects on fertility are
rarely reported. The data may be extrapolated, however,
from the known consequences of therapeutic irradiation
and deliberate experimental exposure.
Cranial irradiation may damage the central nervous
system, includingthehypothalamic-pituitary axisleading
to precocious puberty, hyperprolactinemia, and gonado-
tropin deficiency. Abdominal, pelvic, spinal, or testicular
irradiation may directly affect the gonads, leading to
infertility and impaired sex steroid production.
Thebiological responsetoradiationvaries amongdiffer-
ent tissues and organs, and not only is the total dose of
irradiation received important, but also the number of
fractions and days overwhich itis delivered. Forexample,
a single dose to the testis may be less damaging to the
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germinal epithelium than the same dose received over
severalfractions,whereasthereverseistruefortheovary.
Thelatencyperiodbeforeexpression ofgrosstissueinjury
is in general dose dependent after low doses and dose
independent after high doses because of the partial or
total inhibition ofcell renewal.
Effect of Irradiation on the
Hypothalamic-PituitaryAxis
It is recognized that deficiency ofone or more anterior
pituitary hormones may follow therapeutic external irra-
diationwhen the hypothalamic-pituitary axis iswithin the
radiotherapyfield.Theuseofinterstitialradiotherapyand
heavy-particle therapy is also associated with endocrine
deficits following the selective treatment of pituitary
lesions.
The use ofhypothalamic releasinghormones [thyrotro-
pin-releasing hormone (TRH), growth-hormone releasing
hormone (GRF), corticotropin-releasing hormone (CRF),
and gonadotropin-releasing hormone (GnRH)] have
shown that the pituitary deficiencies following radio-
therapy for nasopharyngeal tumors are likely to be
secondary to hypothalamic damage. This is further sup-
ported by the finding of galactorrhea and hyperpro-
lactinemia in some ofthese patients (1).
Hyperprolactinemia hasbeenwidelyreportedfollowing
external radiotherapy to the hypothalamic-pituitaryOGILVY-STUART AND SHALET
region (2-5): it is likely that it represents damage to the
hypothalamus, resulting in deficiency of endogenous pro-
lactin inhibitory factor. In a study of the changes in
prolactin concentration inpatientswho hadnormalprolac-
tin levels before radiotherapy (37.5-42.5 Gy over 20-22
days) for a pituitary tumor, there was a significant rise in
mean serum prolactin with a peak at 2 years after radi-
otherapy followed by a gradual decline over the next 3
years (6). The hyperprolactinemia was noted to be more
marked in female patients, a finding previously reported
(1,7), although thereason isunclear. Furtherevidence that
the hyperprolactinemia is due to hypothalamic damage is
suggested bytherarityofthisphenomenon afterintersti-
tial radiotherapy with yttrium-90 implants (8,9), in which
the irradiation is almost exclusively confined to the pitui-
tarygland. Apossibleexplanationforthetransientnature
of the hyperprolactinemia, when all other radiation-
induced anterior pituitary hormone deficiencies appear
permanent, is that the radiation induced damage to the
hypothalamic prolactin-inhibitory centers is followed by
the evolution ofdirect damage to the pituitary lactotroph
cells after an interval of several years. An alternative
explanation for the low incidence of hyperprolactinemia
after pituitary yttrium implants is that there may be
hypothalamic damage, but the pituitary lactotroph may
also have been directly damaged by the yttrium and
unable to mount an appropriate prolactin response to
deficiency ofendogenous prolactin inhibitory factor.
The distinction between radiation-induced isolated
hypothalamic damage and combined hypothalamic and
pituitary damage is ofmore than academic interest. Hom-
burg et al. (10) have described good results in womenwith
organic pituitary disease treated with GnRH therapy to
induce ovulation, providingthatthosewho had undergone
hypothalamic-pituitary irradiation were excluded, imply-
ingthatintheselatterpatients directradiation damage to
the pituitary gonadotrophs impaired the gonadotropin
response to pulsatile GnRH.
Gonadotropin Deficiency
Anterior pituitary hormone deficiencies after radi-
otherapy have been documented in five main groups of
patients: those treated for nasopharyngeal carcinomas,
those treated for tumors of the pituitary gland, those
treated for primary brain tumors, children who have
receivedprophylactic cranialirradiationforacutelympho-
blastic leukemia, and patients who haveundergone whole-
body irradiation. The latter three groups are all assumed
to have normal hypothalamic-pituitary function before
radiotherapy, and retrospective studies therefore give an
accurate estimate of the effects of irradiation. Patients
with pituitary disease and nasopharyngeal carcinoma
may, however, showpituitary hormone deficits as a conse-
quence of the underlying tumor or surgical intervention
before radiotherapy. It is therefore only the more recent
prospective studies, which have examined pituitary func-
tion between presentation, surgery, and radiotherapy,
which can adequately ascribe the subsequent pituitary
dysfunction to the individual insults.
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FIGURE 1. Life-table analysis indicating the probabilities of initially
normal hypothalamic-pituitary axes remaining normal after radio-
therapy.
Littley et al. (6) have shown thatfollowing radiotherapy
forpituitarytumors (20-45 Gyin8-15fractions over10-22
days using linear accelerator equipment, 4 or 8 MeV),
anterior pituitary hormone deficiency occurs in a well-
defined order, with the growth hormone (GH) axis the
most susceptible (Fig. 1). In two thirds of patients,
gonadotropin deficiencyoccurs before adrenocorticotropic
hormone (ACTH) deficiency, butintheremaining third the
order is reversed. Thyroid-stimulating hormone (TSH)
secretion is the least vulnerable to such damage. By 3.5
years after this schedule of radiotherapy, 60% will be
gonadotropin deficient, and by8 years almost80%. Atany
one time the prevalence ofgonadotropin deficiency follow-
ing irradiation will depend on the dose ofirradiation, the
radiation schedule, and the time elapsed since radi-
otherapy (Fig. 2). After low-dose cranial irradiation
regimes such as used in leukemia prophylaxis, deficiency
of anterior pituitary hormones other than growth hor-
mone are uncommon (11).
In those patients who consistently receive the highest
doses of irradiation to the hypothalamic-pituitary axis,
such as those treated for nasopharyngeal carcinoma or
rhabdomyosarcoma of facial structures, gonadotropin
deficiency is common. In a series of15 patients irradiated
for nasopharyngeal tumors, (12), 12 had deficiencies of all
anterior pituitary hormones. Endocrine investigations,
including hypothalamic releasing factor tests, indicated
that the hypothalamus was the primary site of radiation
damage. The dose ofirradiation ranged from 50 to 83 Gy,
administered using cobalt 60, kilovoltage X-rays, and
megavoltage X-rays. In alater study (13), 39 of65 patients
had hyperprolactinemia, providing further evidence of
hypothalamic damage after external radiotherapy.
Intheirlargest studyto date, Samaan etal. (4) assessed
110 patients irradiated for nasopharyngeal carcinoma
between the ages of 4 and 74 years and observed a pro-
gressiveriseintheincidence ofanteriorpituitaryhormone
deficiencies with time. The endocrine investigations sug-
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FIGURE 2. The probability ofgonadotropin secretion remaining normal
following radiotherapy, according to the dose schedules used: (-) 20Gy
in8fractions over10-12 days; (-) 35-37.5Gyin15fractions over20-22
days; (...) 40 Gy in 15 fractions over 20-22 days.
gested that both the hypothalamus and pituitary gland
could be affected bythe irradiation. In the children in this
series (14girls13years old oryoungerand18boys14years
old or younger), there was a slightly higher incidence of
both hypothalamic (81%) and pituitary (44%) dysfunction
than in the group as a whole, lending support to the view
that the immature hypothalamic-pituitary axis may be
more vulnerable to radiation damage.
In a retrospective study, Huang (14) reported the
assessment ofhypothalamic-pituitary-gonadal function in
12 women 1-13 years after radiotherapy (60-65 Gy over
30-45 days) for nasopharyngeal carcinoma. Three were
amenorrheic, three were oligomenorrheic, and eight had
galactorrhea. Mean basal gonadotropin levels and the
GnRH-stimulated gonadotropin levels were lower than
normal controls. Five ofthewomenwith galactorrhea also
hadhyperprolactinemia, suggestingahypothalamic lesion
underlying the abnormalities ofthe reproductive axis.
In a prospective study of 31 patients irradiated for a
nasopharyngeal tumor at a mean age of43 years (7), the
hypothalamus and pituitary received mean estimated
doses of 40 and 62 Gy, respectively (24 fractions in 6
weeks). One year after treatment in the males, the mean
basal and GnRH-stimulated follicle-stimulating hormone
(FSH) concentrationswereraisedwhilethebasalluteiniz-
ing hormone (LH) level was unchanged, but the GnRH-
stimulated LH level was reduced. This dichotomy in FSH
and LHpatternsmaybedueto aradiation-induced altera-
tion in pulse frequency of endogenous hypothalamic
GnRH, affecting the relative secretion of LH and FSH
fromthepituitary(15). Itislikelythatintimefrankgonad-
otropin deficiencywill ensue, with lowbasal gonadotropin
levels and reduced gonadotropin responses to GnRH.
Interstitial Therapy and Heavy
Particles
In the treatment ofpituitary tumors which are largely
confined to the pituitary fossa, it has been the practice in
somemedicalcenterstoadministerlargedoses (upto1500
Gy) of irradiation to the tumor by implanting seeds of
radioactive yttrium-90 or gold-198. This therapy has also
been used to ablate the pituitary gland in patients with
metastatic malignancy and diabetic retinopathy. Yttrium-90
is a 13-emitter, and therefore the radiation dose is well
localized (16). There appears to be no damage to the
hypothalamus, as demonstrated by the virtual absence of
treatment-induced hyperprolactinemia in these patients
(8,9). The consequences of 198Au therapy are less well
researched, but as a y-emitter its effects may not be
entirely confined to the pituitary region. Diabetes insip-
idus may occur following interstitial radiotherapy, pre-
sumably due to damage to the pituitary stalk or
hypothalamus and has been reported as occurring tran-
sientlyin asmanyas50% ofpatients (17) andpermanently
in 1 of 16 patients treated for Cushing's disease (8). The
earlyonsetand recoveryinthemajorityofcases suggests
thatthis complication maybe related to physical interven-
tion rather than irradiation.
There may be deficiencies of all anterior pituitary hor-
monesafterinterstitialradiotherapywithevidenceofdose
dependency. The relative sensitivity ofthe different axes
appears tobeGH first, followedbygonadotropins, ACTH,
andTSH,the sameorderinwhichthe axes areaffectedby
hypothalamic damage due to external radiotherapy.
Damage is almost entirely localized to the pituitary gland
itself, with only two cases of radiation-induced hyper-
prolactinemia to suggest hypothalamic or pituitary-stalk
damage (8). The relative radioresistance of the pituitary
tissue is confirmed by normal residual function in the
majority despite the very high doses of irradiation used
(up to 1500 Gy). For example, one of 21 female patients
developed GH deficiency, three showed partial ACTH
deficiency, and none had evidence of treatment-induced
TSH deficiency following 90Y implantation for prolac-
tinoma (18). More recently it has been suggested that the
incidence of hypopituitarism may be extremely low after
interstitial therapywith a relatively low dose of90Y (200-
500 Gy) for prolactinoma (19), despite a high therapeutic
efficacy.
Total Body Irradiation
Endocrine dysfunction has been reported after total
body irradiation (TBI), which is usually used to prepare
patientswithhematologicalmalignanciesforbonemarrow
transplantation. Although impaired GH secretion after a
singlefraction dose of10Gyhasbeenreportedin children
(20), the elevated basal and GnRH stimulated gonadotro-
pin levels in patients with gonadal damage following their
TBI and preparative chemotherapy suggests that
gonadotropin secretion is intact. Similarly, in adults who
received 12 Gy TBI in six fractions over 2 days, there was
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no evidence of gonadotropin or any other pituitary hor-
mone deficiency (21).
Precocious Puberty
Early and precocious puberty occurs in some children
receiving cranial irradiation for brain tumors (22,23) and
acute lymphoblastic leukemia (24). Although both sexes
are affected, at lower radiation doses the female appears
more vulnerable (24-26). The age of pubertal onset is
positivelycorrelatedtotheageatirradiation: theyoungest
at irradiation therefore have the most profound disturb-
ances inthetimingofpuberty. Bydefinition,gonadotropin
deficiency is unusual in these children, which suggests
that the CNS mechanism intrinsically responsible for
restraining puberty is more vulnerable to the effects of
radiation than gonadotropin secretion by the hypothal-
amic-pituitary axis.
Radiation and the Testis
The testis is one ofthe mostradiosensitive tissues, with
a direct radiation dose as low as 0.15 Gy causing a signifi-
cant depression in the sperm count and temporary
azoospermia occurring after doses of0.3 Gy (27). Irradia-
tion ofthe testis may occur during therapeutic and diag-
nostic procedures as well as from occupational exposure.
Thetestis mayreceive ascattered dosefromnearbypelvic
or abdominal irradiation fields or be directly irradiated
such as in the prophylactic or relapse treatment ofleuke-
mia. The allowable occupational radiation exposure level
per year will probably have little effect on testicular
function, but accidental exposure, for example, during
nuclear reactor accidents, may result in whole body expo-
sure at doses below the threshold for lethality but above
those capable ofinducing long-term sperm count depres-
sion.
An understanding ofthe process ofspermatogenesis in
normal men leads to a better appreciation of radiation
effects on the testis. No proliferation occurs after irradia-
tion of either Leydig or Sertoli cells. In general, lethally
irradiated cells die during division. Differentiating sper-
matogonia are very radiosensitive, and after doses as low
as 1 Gyboththeirnumbersandthatoftheirdaughtercells,
thepreleptotene spermatocytes, are severelyreduced (27).
Thedosesofirradiation requiredtokillspermatocytes are
higher than for spermatogonia (2-3 Gy results in an
inability to complete maturation division, with a resultant
decrease in spermatid numbers). Spermatids show no
overt damage, butafter4-6Gytheresultant spermatozoa
are significantly decreased in number, signifying covert
spermatid damage. Due to the radiosensitivity of sper-
matogonia, spermatocytes, and, ultimately, spermatids
disappear from the testis after irradiation. The combined
life span of spermatocytes and spermatids is about 46
days, and transport through the epididymis and vas def-
erens takes 4-12 days. Thus, during the first 50-60 days
after low dose irradiation (1.5-2 Gy), sperm production
remains above 50% of control values and then drops
dramatically with resultant temporary oligo- or azoosper-
mia. The time period for depletion of sperm is consistent
with the kinetics of spermatogenesis in the unirradiated
testis, suggesting that the kinetics are not altered by
irradiation. Higher doses cause a more rapid onset of
oligospermia and azoospermia by a direct effect on the
later stages as well as earlier stages ofsperm production.
Recovery takes place from the surviving stem cells
(type A spermatogonia), and proliferation of stem cells
results in regeneration of stem cell numbers. Some sper-
matogonia differentiate, so that spermatocytes and later
spermatids appear in the testis, resulting in repopulation
of the germinal epithelium with germ cells. With single
dose exposures, complete recovery (i.e., return to pre-
irradiation sperm concentrations and germ cell numbers)
takes place within 9-18 months after less than 1 Gy, 30
months for 2-3 Gy, and 5 or more years after 4-6 Gy.
The most precise and complete data on the effects of
radiation on the testis are from studies on healthy volun-
teers from the Washington and Oregon state penitenti-
aries,whoreceived 250KvpX-raystothetestesinasingle
dose (27-29). In these studies, pretreatment baseline hor-
monal and semenvalues were obtained for several months
in each individual, radiation doses were accurately mea-
sured, and the volunteers were healthy, thereby eliminat-
ing both the complicating effects of disease and adjuvant
chemotherapy on spermatogenesis. In each case the testi-
cular tissue was fixed appropriately, permitting quantita-
tive determination of cells at specific spermatogenic
stages.
Irradiation ofthe testis during the radiotherapy treat-
ment of cancer usually involves fractionated exposures.
Under certain conditions, fractionation causes more stem
cell killing than single dose treatments, although this has
not been proven in man.
Hahn et al. (30) carried out serial semen analysis on 11
cancerpatientswhohadreceived largepelvicfieldirradia-
tion or interstitial 125I seeds implanted in the prostate
gland. Total calculated dose to the testis ranged from 1.18
to 2.28 Gy delivered in 24-35 fractions. All patients suf-
fered temporarylaspermiabeginningabout3months after
irradiation. Recovery of spermatogenesis was first noted
between10 and18monthsafterirradiationinfivepatients.
The same group (31) studied a cohort of patients who
received total fractionated doses of 0.19-1.78 Gy to the
remaining testis following unilateral orchidectomy for
seminoma. Azoospermia occurred in 10 of14 patients who
received over 0.65 Gy to the testis. Sperm reappeared in
thesemenwithin30-80weeksafterthe startoftreatment.
Males in whom abdominal irradiation (inverted Y
abdominal, pelvic, and inguinal fields) is given for
Hodgkin's disease may receive a scatter dose of irradia-
tion to the testes . Speiser et al. (32) studied 10 such men
who received an average daily dose of0.12 Gy, resultingin
a total dose of1.4-3.0 Gy . All were azoospermic, but only
two patients were followed for longer than 16 months. Of
the men studied retrospectively, 27.5% (33) were either
oligospermic or had a normal sperm count following simi-
lar radiation treatment and scatter dosage to the testes,
but the follow-up period was longer for these latter
patients, suggesting that recovery of spermatogenesis
may have taken place.
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After fractionated courses of irradiation, azoospermia
has been induced by a testicular dose as low as 0.35 Gy
(34). After a radiation dose of between 2 and 3 Gy, the
primary site of damage is the germinal epithelium, with
recovery ofspermatogenesis sometimes delayed for up to
10 years or more.
Tsatsoulis et al. (35) evaluated both Leydig and Sertoli
cellfunction in18men 21-49years oldwho hadundergone
unilateralorchidectomyforatesticularseminomafollowed
by30 Gyirradiation in 20 fractions over27-28 days to the
remaining testis. Basal serum levels of testosterone,
gonadotropins, and inhibin were estimated. The median
testosterone level (12.7 nmole/L) was signiflcantly less
than in normal controls (20.0 nmole/L), and six men had
levels belowthe normal adult male range. In addition, the
medianbasal LHlevelwassignificantlyhigher(14.5 IU/L)
than in controls (5.5 IU/L), and the testosterone/LH ratio
significantly decreased suggesting Leydig cell damage.
Damage to the germinal epithelium was confirmed by
azoospermia, reduced inhibin levels compared with con-
trols, raised FSH levels, and a lowered inhibin/FSH ratio.
In childhood, neither the threshold dose of irradiation
required to damage the germinal epithelium, northe dose
above which irreversible damage occurs are known. The
relationship between vulnerability to radiation-induced
damage to the germinal epithelium and pubertal status is
contentious,buttheprepubertaltestismayundoubtedlybe
damaged irreversibly by irradiation.
Low doses, 3-9 Gy, received as a scattered dose to the
testes in 20 fractions over 4 weeks during the childhood
treatment of a nephroblastoma resulted in oligo- or
azoospermia many years later. Eight of 10 men studied
between the ages of 17 and 36 years showed a greatly
reduced sperm count (0-5.6 million), and 7 of these men
had an elevated FSH level. All patients progressed
through puberty spontaneously, and all except one, who
hadchronicrenalfailure,hadnormal LHandtestosterone
levels, indicating normal Leydig cell function (36).
With doses ofdirect testicular irradiation of24-25 Gy,
the germinal epithelium is completelyablated, and Leydig
cellfunctionisseriouslyaffectedinmostpatients. Tenof12
boys showed evidence of Leydig cell dysfunction 10
months-8.5 years after testicular irradiation (24 Gy in 12
fractions over 18 days) for acute lymphoblastic leukemia,
indicated bya lowtestosterone response to an acute bolus
of human chorionic gonadotropin (hCG) or an increased
basal plasma LH level, orboth (37). Similar findings were
reportedbyLeiperetal. (38). Shaletetal. (39) showedthat
Leydig cell failure occurs soon after irradiation, with no
evidence ofrecovery up to 5 years after irradiation. Most
of these boys therefore require androgen replacement
therapy to enable normal pubertal development and to
allow normal sexual function in adult life.
Aftertheuseoflowerdosesoftesticularirradiation (12-
15 Gy) for leukemia prophylaxis, Castillo et al. (40)
reported normal pubertal development in 12 of 13 boys,
with a normal basal testosterone level and testosterone
response to hCG stimulation. Elevated basal or post-
GnRH stimulated LH levels in the pubertal boys suggest
subclinical Leydig cell damage is common. Seven boys
were old enough to perform semen analysis, and all were
azoospermic.
Lowerdosesoftesticularirradiation maybereceivedby
boys undergoing TBI for a bone marrow transplant or
scatter from spinal fields used in craniospinal irradiation
administered for some childhood brain tumors. The
degree of testicular damage to the germinal epithelium
and Leydigcellis dependent ontheradiation dose andthe
age and pubertal stage ofthe boy (41).
Radiation and the Ovary
Information on the effects of irradiation on the ovary
are derived from the studies ofthe previous use ofpelvic
radiotherapy for benign uterine bleeding and to restore
normal menstruation in youngwomen in the treatment of
infertility. Further data have been acquired in women
receiving irradiation to the ovary during the treatment of
malignant tumors of the abdomen and during accidental
exposuresuchasfromthenuclearexplosionsofHiroshima
and Nagasaki.
The ovaries ofanewborn girl contain afinite numberof
oocytes (about 2 million), which become reduced with
increasing age. These oocytes are in the middle of a
meiotic division that only becomes completed shortly
before ovulation many years later, and mitotic multiplica-
tion of oocytes is therefore impossible. The population of
oocytes continues to decline with age until menopause,
when few oocytes survive.
After irradiation, damaged oocytes either undergo
repair or are eliminated from the ovary by phagocytosis.
The time atwhich degenerative changes occuris indepen-
dent of the dose administered, but dose influences the
number ofoocytes affected.
The susceptibility to radiation-induced cell death de-
pends on the developmental stage of the germ-cell at the
time of exposure. The oogonia in prenatal life that are
undergoing mitosis are highly susceptible to radiation-
induced cell death. As the cells pass through the stages of
meiotic division, resistance to radiation damage generally
increases. Mammalian oocytes enter a prolonged resting
phase shortly after birth, which persists throughout fol-
licular growth and terminates shortly before ovulation.
The radiosensitivity of the oocyte varies during the
growth phase and is dependent on the age, the strain of
the animal, and the species. Inwomen, primordial oocytes
are more resistantto the effects ofradiation than oocytes
in growing follicles.
The use ofX-rays in the treatment ofsterilitybetween
1924 and 1957 (42) provided information on low dose
irradiation ofthe ovaries. In threeweeklysessions, atotal
estimated dose of 0.215 Gy was delivered to the pituitary
and 0.065 Gy to the ovary. No deleterious effect was
observed, and 308 of 794 women conceived and bore nor-
mal children.
Irradiation has been used for benign uterine bleeding
for the return of normal menstruation. Of 1817 women
treatedwithintrauterine radiumforuterinebleeding(43),
311 were less than 40 years of age at irradiation, and 19
have subsequently become pregnant, with 33 conceptions.
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There were 13 miscarriages, 7 stillbirths, and only 6 live
births, 1 ofwhom was mentally retarded. The estimated
radiationdosetotheovarieswas0.8Gyinwomenlessthan
20years and1.2Gyinages20-40years.Theradiationdose
tothe uteruswas atleast24Gy, animportantfactorinthe
high rate ofmiscarriage.
Although a permanent menopause can be caused in
womenatleast40yearsoldbyatotalradiationexposureof
4-7Gydelivered in onetofourfractionsusing200-250 kV
X-rays, estimates ofthe 50% probability level for perma-
nent sterility in young women is approximately 20 Gy
delivered over a 6-week period. If the radiation dose is
delivered in a greater number offractions, the damage to
the ovary and consequent chance ofinfertility is likely to
be less. In women with metropathia hemorrhagia treated
withirradiationtoinduceanartificialmenopause,Dolland
Smith (44) found that 97% of2068 women failed to men-
struate again aftertwotofourfractionated exposures to a
total estimated ovarian dose of3.6-7.2 Gy.
The treatmentofHodgkin's disease isinfluencedbythe
extent ofthe disease. Certain patients receive irradiation
tothelymphnodesalongtheiliacvessels.Astheovarieslie
in this area, theywill receive a dose ofabout 35 Gy, which
inevitably causes ovarian failure.
TIansposition ofthe ovaries (oophoropexy) before irra-
diation with a consequent reduction in the dose to the
shielded ovaries to amaximumof6Gyover12-45days has
decreased the incidence of amenorrhea by over 50% (45).
Nonetheless, the exact benefit derived from oophoropexy
in women requiringinverted "Y" therapy is controversial.
The extent ofthe disease needs to be carefully evaluated
before considering oophoropexy, and then the procedure
needs to be performed with accuracy and care.
Effect of Irradiation on Ovarian Function
in Childhood
There have been few studies of ovarian function after
irradiation uncomplicated by the effects of gonadotoxic,
cytotoxic chemotherapy. Twenty-seven of38 patients who
receivedwholeabdominalirradiation(20-30Gyover25-44
days) in childhood failed to undergo or complete pubertal
development, and afurther10laterdeveloped apremature
menopause (median age 23.5years). All had elevated FSH
levels andlowestradiollevels. Sexsteroidreplacementwas
required to induce breast development and prevent subse-
quent osteoporosis (46,47). Morphological studies after
whole abdominal irradiation (20-30 Gy) have revealed
marked inhibition of follicular growth and severe reduc-
tion in oocyte numbers (48).Whenflankirradiation rather
thanwholeabdominalwasused,only1 of15girlsdeveloped
pubertal failure. Only one patient, who developed pubertal
failure afterwhole abdominal irradiation and required sex
steroid therapy to acquire normal secondary sexual char-
acteristics, showed evidence of reversibility of ovarian
function with a documented conception at the age of22.7
years (47). Recent studies have indicated that the spinal
component ofcraniospinal irradiation forthe treatment of
braintumors (49) and TBI beforebonemarrowtransplan-
tation(50)maycauseovariandysfunctionduetoradiation-
induced ovarian damage.
Ithas been estimated from 18 girlswho received 30 Gy,
megavoltage,wholeabdominalradiotherapythattheLD50
for the human oocyte does not exceed 4 Gy (51), and in
conjunction with the information about the position ofthe
ovaries in relation to the radiation field, the predicted age
at ovarian failure can be calculated approximately. This
mayprovide afactualbasis forfertilitycounselingin such
patients who receive irradiation in childhood or young
adult life.
Radiation and the Uterus
In those women in whom ovarian function is preserved
butin whom the uterus has been involved in the radiation
field,thereisevidencethatradiationchangestotheuterus
result in failure to carry a pregnancy, which has implica-
tions for in vitro fertilization in women with concomitant
ovarian failure.
Followingthetreatmentofbenignuterinebleedingwith
intrauterine radium, in which the dose of irradiation
received by the endometrium was at least 24 Gy, 13 of33
conceptions ended in miscarriage, and a further seven
werestillborn. In38womenwhoreceivedwholeabdominal
irradiation (20-30 Gy) during childhood (47), there were
six conceptions in four patients, all ending in second tri-
mester miscarriages. Critchley et al. (52) have studied
these womenin more detail byevaluatinguterine physical
characteristics and blood flow as well as assessing the
functional uterine response to exogenous sex steroid
replacement. Compared with women with premature
ovarian failure not exposed to irradiation, those who
received whole abdominal irradiation in childhood had a
significantly smaller uterine length, implying that pre-
pubertal exposure to irradiation may have an irreversible
effectonuterinedevelopmentandvasculature. Inaddition,
intheselatterwomen, theendometriumwas unresponsive
tophysiologicalserumlevelsofestradiolandprogesterone
attained by exogenous administration. Doppler signals
fromtheuterinearterieswereabsentinmost. Itisunclear
whether this is a consequence of damage to the micro-
vasculature ofthe uterus and associated blood supplyorif
the insult is at the level of the sex steroid receptors. As
appropriatevascularization and subsequentgrowth ofthe
endometrium are essential, however, for implantation and
successful continuation of pregnancy, it is unlikely that
women who have received abdominal irradiation in child-
hood will be able to sustain a pregnancy to term.
Conclusion
Thegonads arehighlysensitivetotheeffects ofirradia-
tion, with resultant temporary or permanent effects on
fertility depending on the dose ofirradiation received. In
addition totheeffectonthegermcells, sexsteroidproduc-
tion may be impaired. In the adult this will result in
symptoms ofsex steroid deficiency and in the young child
pubertal developmentwill either not occur or be arrested.
Irradiation to theheadmayhave aneffectonthetimingof
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the onset of puberty or on the hypothalamic-pituitary
control of gonadotropin secretion, with subsequent infer-
tility and sex steroid deficiency. These conclusions are
derived from reports of known controlled radiation doses
to individual patients. Nuclear atomic accidents will
obviously have profound effects on the surrounding popu-
lation. Global nuclear war resulting in less than lethal
doses of emitted irradiation may render the surviving
population sterile.
We thank Serono Laboratories (UK) Limited for financial support.
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